Summary
It has been reported that endothelial cells suspended in three-dimensional type I collagen gels can be induced to undergo tube formation by 12-o-tetradecanoyl phorbol 13-acetate (TPA). In this report, we show that TPA-induced endothelial cell tube formation can be further enhanced by the addition of other matrix components in the collagen gels. In the presence of TPA, both high molecular weight hyaluronate and chondroitin sulfate elicit a dose-dependent stimulation of tube formation. The enhanced tube formation appears to be due to an increase in the number of cells undergoing morphogenesis as the average length per tube is not obviously increased. Concomitant with the increased cell morphogenesis, there is an increase in proteolytic activity secreted by the cells. Treatment of cells with cycloheximide suppresses hyaluronate- and chondroitin sulfate-enhanced cell morphogenesis and proteolytic activity suggesting that new protein synthesis, perhaps proteases, is necessary for endothelial cell morphogenesis. The possible role of the production of proteolytic activity in endothelial cell tube formation is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berg, R. A. Determination of 3- and 4-hydroxyproline. In: Cunningham, L. W.; Frederiksen, D. W. eds. Methods in enzymology Vol. 82. New York: Academic Press; 1982:372–398.
Berse, B.; Brown, L. F.; Vander-Water, L., et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3:211–220; 1992.
Breier, G.; Albrecht, U.; Sterrer, S., et al. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521–532; 1992.
Crumley, G.; Bellot, F.; Kaplow, J. M., et al. High-affinity binding and activation of a truncated FGF receptor by both aFGF and bFGF. Oncogene 6:2255–2262; 1991.
Dionne, C. A.; Crumley, G.; Bellot, F., et al. Cloning and expression of two distinct high affinity receptors cross-reacting with acidic and basic fibroblast growth factor. EMBO J. 9:2685–2692; 1990.
Doctrow, S. R.; Folkman, J. Protein kinase C activators suppress stimulation of capillary endothelial cell growth by angiogenic endothelial mitogens. J. Cell Biol. 104:679–687; 1987.
Folkman, J. What is the role of endothelial cells in angiogenesis? Lab. Invest. 51:601–604; 1984.
Folkman, J.; Klagsbrun, M. Angiogenic factors. Science 235:442–447; 1987.
Folkman, J.; Shing, Y. Angiogenesis. J. Biol. Chem. 267:10931–10934; 1992.
Folkman, J.; Watson, K.; Ingber, D., et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58–61; 1989.
Grant, D. S.; Tashiro, K.-I.; Segui-Real, B., et al. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Cell 58:933–943; 1989.
Grant, D. S.; Lelkes, P. I.; Fukuda, K., et al. Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell. Dev. Biol. 27A:327–336; 1991.
Ingber, D. E.; Madri, J. A.; and Folkman, J. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology 119:1768–1775; 1986.
Iruela-Arispe, M. L.; Hasselaar, P.; Sage, H. Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab. Invest. 64:174–186; 1991.
Jackson, R. L.; Busch, S. J.; Cardin, A. D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71:481–539; 1991.
Mignatti, P.; Tsuboi, R.; Robbins, E., et al. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108:671–682; 1989.
Montesano, R.; Orci, L. Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42:469–477; 1985.
Montesano, R.; Vassalli, J.-D.; Baird, A., et al. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA. 83:7297–7301; 1986.
Montesano, R.; Pepper, M. S.; Belin, D., et al. Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases. J. Cell. Physiol. 134:460–466; 1988.
Morris, P. B.; Hida, T.; Blackshear, P. J., et al. Tumor-promoting phorbol esters induce angiogenesis in vivo. Am. J. Physiol. 254:C318-C322; 1988.
Moses, M. A.; Langer, R. Inhibitors of angiogenesis. Bio/Technology 9:630–634; 1991.
Orlidge, A.; D’Amore, P. A. Cell specific effects of glycosaminoglycans on the attachment and proliferation of vascular wall components. Microvasc. Res. 81:41–53; 1987.
Pepper, M. S.; Belin, D.; Monteasano, R., et al. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell. Biol. 111:743–755; 1990.
Ruoslahti, E. Proteoglycans in cell regulation. J. Biol. Chem. 264:13369–13372; 1989.
Schreiber, A. B.; Winkler, M. E.; Derynck, R. Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science 232:1250–1253; 1986.
Thomas, K. A.; Rios-Candelore, M.; Gimenez-Gallego, G., et al. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin I. Proc. Natl. Acad. Sci. USA 82:6409–6413; 1985.
West, D. C.; Kumar, S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp. Cell Res. 183:179–196; 1989.
Yang, E. Y.; Moses, H. L. Transforming growth factor-β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol. 111:731–741; 1990.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, DY., Kao, CH., Yang, V.C. et al. Glycosaminoglycans enhance phorbol ester-induced proteolytic activity and angiogenesis in vitro. In Vitro Cell Dev Biol - Animal 30, 777–782 (1994). https://doi.org/10.1007/BF02631301
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02631301